Company Analysis

CapsoVision, Inc. (CV)

Nasdaq: CV · Electromedical & Electrotherapeutic Apparatus · Saratoga, CA · filing with the SEC since 2006
Grade5.0
◀ Past 5.1● Present 4.9▶ Future 5.1
5 est.

Who runs CapsoVision, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Wang Kang-Huai
President and Chief Executive Officer. First filing Jul 2025, latest Jun 3, 2026, 0 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
12 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Wang Kang-HuaiPresident and Chief Executive OfficerJul 2025Jun 3, 2026none
Atkinson Douglas PatrickHead of Global SalesJul 2025Jun 3, 2026none
Garcia David MichaelSr. VP of FinanceNov 2025Jun 3, 2026none
Petersen Rebecca AnnDirector of Clinical AffairsJul 2025Aug 22, 2025none
Lundquist Kevin MichaelChief Financial OfficerJul 2025Jul 1, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Shields David StanleydirectorJul 2026Jul 2, 2026none
Gouw Julia SdirectorJul 2025Jul 1, 2026none
Harari MicheledirectorJul 2025Jul 1, 2026none
Imperial Joanne CaroldirectorJul 2025Jul 1, 20261 · $0.00
King Wen-Herng HenrydirectorJul 2025Jul 1, 2026none
Kuo Hui YingdirectorJul 2025Jul 1, 2026none
Tsai Chen LungdirectorJul 2025Jul 1, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Harari Eliyahou Et Al10% ownerJul 2025Sep 23, 2026none
Shen Ching Hang10% ownerMar 2026Sep 23, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CV · research, not advice